IND, NDA....not a drug? what would those huge drug companies want to buy them out of the clinical III trials (as Regen BioPharma suggests in their 'business' model).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.